University Gap Funding and Accelerator Community News

Yale Ventures is excited to announce that applications for the 2025-2026 accelerator funds open on September 2, 2025. Yale accelerator funds are open to faculty innovators and their teams working on cutting-edge translational research in the life sciences, digital health, autoimmunity and allergic disease, engineering, and physical sciences. To date,

Europe produces world-class scientific research from its top universities, yet struggles to convert breakthroughs into global companies, leaving many innovations trapped in labs. U2V, short for University2Ventures, addresses this through its newly closed €60 million Fund I, which targets pre-seed and seed-stage deeptech spin-offs in AI, novel computing, industrial tech,

Boston — Today, MassVentures announced the launch of the rebranded Massachusetts Academic Spinouts Center (MASC), formerly known as the Mass Tech Transfer Center, to accelerate academic spinout company formation and success. MASC will engage with the entrepreneurial ecosystem and Massachusetts’ world-class academic institutions and research labs to help inventors, researchers, and entrepreneurs to

WORCESTER—Worcester Polytechnic Institute has received a $3 million gift from alumnus Paul Covec ’64 to support innovation, entrepreneurship and commercialization efforts led by faculty and students, the university announced. The gift establishes the Paul A. Covec ’64 Innovation and Commercialization Fund, an endowed resource designed to help promising ideas move

RALEIGH — NCInnovation, the university research accelerator nonprofit, has announced the approval of $10 million in funding for 13 projects spanning 11 schools in the UNC System. “NCInnovation’s December 2025 slate represents some of the strongest university-to-industry opportunities emerging anywhere in the country,” said Michelle Bolas, the group’s acting president

The Blue Sky Proof-of-Concept (PoC) Fund will accelerate bold, neurotech breakthroughs nationwide, paving the way for a new generation of neurotechnologies to treat conditions such as depression, dementia, chronic pain, epilepsy, and nervous system injuries. The fund will support six-month hypothesis-testing projects with the potential to reshape a future where